RSI Drug Doses (Adult)
Rapid Sequence Intubation — weight-based dose calculator. Always confirm with local formulary.
Detailed Guide Coming Soon
We're working on a comprehensive educational guide for the RSI Drug Dose Calculator (Adult) in your language. The content below is shown in English.
What is RSI Drug Dose Calculator (Adult)?
▾
In high-acuity clinical environments, Rapid Sequence Intubation (RSI) represents one of the most critical, high-liability procedures performed by healthcare teams. From an operational and risk-management perspective, RSI is a highly structured clinical workflow designed to secure a definitive airway in patients with compromised respiratory function or those at immediate risk of aspiration. By simultaneously administering a rapid-acting sedative-hypnotic agent and a neuromuscular blocking agent (NMBA), clinical teams can induce unconsciousness and complete flaccid paralysis within seconds, facilitating safe endotracheal tube placement while minimizing the time window during which the airway is unprotected. For medical directors, emergency department administrators, and clinical risk managers, standardizing RSI drug dosing is a vital strategy for mitigating clinical error and optimizing patient outcomes. Medication dosing errors during emergency intubations are a primary driver of preventable adverse events, prolonged intensive care unit (ICU) stays, and medical malpractice claims. Implementing a standardized, weight-based calculation protocol ensures that clinical providers can make rapid, mathematically precise dosing decisions under extreme cognitive load, directly supporting institutional quality metrics and clinical governance standards. Ultimately, this calculator serves as a decision-support tool that translates patient-specific physical parameters into precise, actionable clinical directives. By establishing a reliable, evidence-based dosing framework for first-line induction agents and paralytics, healthcare organizations can reduce clinical variability, streamline procedural throughput, and protect both patient safety and institutional resources.
Calkulon makes complex calculations simple — built for students and everyday problem-solvers.
Formulė
▾
Ketamine dose = 1–2 mg/kg IV; Propofol dose = 1.5–2 mg/kg IV; Succinylcholine dose = 1.5 mg/kg IV; Rocuronium dose = 1.2 mg/kg IV; Fentanyl pretreatment = 3 mcg/kg IVVariable Legend
▾
| Symbol | Vardas | Vienetas | Aprašymas |
|---|---|---|---|
| W | Patient Weight | kg | The measured or estimated total body weight of the patient, which serves as the foundational variable for all weight-based clinical calculations. |
| D_ind | Induction Agent Dose | mg/kg | The weight-based dosing coefficient for the selected sedative-hypnotic agent, adjusted for the patient's hemodynamic status. |
| D_nmb | Neuromuscular Blocking Agent Dose | mg/kg | The weight-based dosing coefficient for the paralytic agent, chosen based on patient-specific contraindications and desired duration of action. |
| D_pre | Pretreatment Agent Dose | mcg/kg | The weight-based dosing coefficient for pretreatment medications, such as fentanyl, used to mitigate adverse physiological reflexes during laryngoscopy. |
| D_rev | Reversal Agent Dose | mg/kg | The weight-based dosing coefficient for Sugammadex, used to achieve immediate reversal of rocuronium-induced neuromuscular blockade. |
How to RSI Drug Dose Calculator (Adult)
▾
- 1Phase 1 — Clinical Preparation and Logistics: Assemble all primary and backup airway equipment (laryngoscopes, endotracheal tubes, suction systems, and rescue airway devices), establish dual patent intravenous access, and initiate continuous hemodynamic monitoring including pulse oximetry, ECG, and waveform capnography.
- 2Phase 2 — Pre-oxygenation Protocol: Administer high-flow 100% oxygen via a non-rebreather mask or non-invasive positive pressure ventilation for a minimum of 3 to 5 minutes to maximize the patient's functional residual capacity and extend the safe apnea window.
- 3Phase 3 — Pharmacological Pretreatment (Optional): Administer fentanyl at 3 mcg/kg IV approximately 3 minutes prior to induction to blunt the sympathetic reflex and prevent dangerous spikes in intracranial pressure or cardiovascular shear stress.
- 4Phase 4 — Rapid Sedation Execution: Deliver the calculated weight-based bolus of the selected induction agent (e.g., ketamine, propofol, or etomidate) to achieve rapid, predictable loss of consciousness.
- 5Phase 5 — Paralysis and Neuromuscular Blockade: Immediately follow the induction agent with a rapid IV bolus of the chosen neuromuscular blocker (succinylcholine or rocuronium) to achieve complete skeletal muscle relaxation.
- 6Phase 6 — Laryngoscopy and Airway Securing: Perform direct or video laryngoscopy once adequate muscle relaxation is achieved, place the endotracheal tube, inflate the cuff, and verify correct placement utilizing quantitative waveform capnography.
- 7Phase 7 — Post-Intubation Stabilization and Maintenance: Secure the endotracheal tube, initiate mechanical ventilation protocols, obtain a confirmatory chest X-ray, and establish a continuous sedation and analgesia infusion to maintain patient comfort and ventilator synchrony.
Worked Examples
▾
Fentanyl pretreatment is prioritized to prevent sympathetic surges that raise intracranial pressure during laryngoscopy.
To calculate the pretreatment opioid dose: 3 mcg/kg × 70 kg = 210 mcg IV. The induction sedative dose of Ketamine is calculated at 1–2 mg/kg: 1 mg/kg × 70 kg = 70 mg, and 2 mg/kg × 70 kg = 140 mg. The depolarizing neuromuscular blocker Succinylcholine is dosed at 1.5 mg/kg: 1.5 mg/kg × 70 kg = 105 mg IV.
Ketamine is selected as the induction agent of choice due to its ability to preserve sympathetic vascular tone in hypotensive states.
Propofol is contraindicated in hemodynamically unstable patients due to the risk of profound vasodilation and cardiac arrest. Ketamine dosing is calculated at 1–2 mg/kg: 1 mg/kg × 80 kg = 80 mg, and 2 mg/kg × 80 kg = 160 mg IV. Succinylcholine is calculated at 1.5 mg/kg: 1.5 mg/kg × 80 kg = 120 mg IV to achieve rapid paralysis.
Succinylcholine is contraindicated due to the risk of triggering lethal cardiac arrhythmias from hyperkalemia; Rocuronium is utilized instead.
Rocuronium is dosed at an emergency RSI-specific rate of 1.2 mg/kg: 1.2 mg/kg × 60 kg = 72 mg IV. The induction agent Ketamine is calculated at 1–2 mg/kg: 1 mg/kg × 60 kg = 60 mg, and 2 mg/kg × 60 kg = 120 mg IV. Sugammadex is kept on standby at a rescue dose of 16 mg/kg: 16 mg/kg × 60 kg = 960 mg IV.
Ketamine provides beneficial bronchodilation through sympathetic stimulation, making it the ideal agent for severe reactive airway disease.
The bronchodilating induction agent Ketamine is calculated at 1–2 mg/kg: 1 mg/kg × 90 kg = 90 mg, and 2 mg/kg × 90 kg = 180 mg IV. The neuromuscular blocker Succinylcholine is calculated at 1.5 mg/kg: 1.5 mg/kg × 90 kg = 135 mg IV to minimize time to secure the airway.
Real-World Applications
▾
Standardizing emergency airway protocols in high-volume urban trauma centers to minimize procedural delays and reduce clinical error rates.
Establishing standardized pre-hospital intubation guidelines for flight paramedics and critical care transport teams operating in high-stress environments.
Optimizing clinical pathways in surgical suites for patients requiring urgent general anesthesia who are at high risk of gastric aspiration.
Developing quality improvement and peer-review audits within hospital medicine departments to evaluate compliance with evidence-based dosing guidelines.
Designing simulation-based training curricula for emergency medicine residents and critical care fellows to reinforce rapid, accurate clinical decision-making.
Special Cases
▾
Clinical Management of Traumatic Brain Injury (TBI)
When executing an RSI protocol for patients with acute traumatic brain injury, the primary clinical objective is to maintain cerebral perfusion pressure while preventing surges in intracranial pressure (ICP). Standard dosing algorithms must be carefully balanced with pretreatment agents like fentanyl to blunt the hypertensive reflex associated with direct laryngoscopy. Systemic hypotension must be aggressively avoided, as even a single episode of hypotension is strongly correlated with a doubling of mortality in TBI patients.
Hemodynamic Instability and Shock States
In patients presenting with distributive, cardiogenic, or hypovolemic shock, the standard weight-based dosing of induction agents can precipitate catastrophic cardiovascular collapse. Vasodilatory agents like propofol should be avoided or severely dose-reduced. Ketamine or etomidate are preferred, but even these agents should be titrated downward in severe shock states, as the endogenous catecholamine depletion in these patients limits their normal compensatory sympathetic responses.
Dosing Considerations in Extreme Obesity
When calculating RSI medication requirements for morbidly obese patients, clinicians must distinguish between total body weight (TBW) and ideal body weight (IBW). Hydrophilic drugs, such as non-depolarizing neuromuscular blockers, do not distribute significantly into adipose tissue and should generally be dosed based on IBW to prevent prolonged paralysis. Conversely, depolarizing blockers like succinylcholine require dosing based on TBW due to increased pseudocholinesterase activity in obese patients.
Obstetric Airway Emergencies
RSI in the pregnant patient requires heightened awareness of rapid maternal desaturation and a high risk of gastric aspiration. Due to physiological changes of pregnancy, including decreased functional residual capacity and increased oxygen consumption, the safe apnea window is significantly shortened. Dosing protocols must be executed with flawless efficiency, and clinicians should always prepare for a challenging airway scenario due to upper airway mucosal edema.
Pediatric Protocol Deviations
While this tool is calibrated specifically for adult populations, pediatric airway management involves distinct anatomical, physiological, and pharmacological differences. Weight-based dosing in pediatric patients requires meticulous calculation to avoid toxicities, and co-morbidities such as bradycardia are more prevalent, often requiring pretreatment with anticholinergics like atropine. Adult calculators must not be applied to pediatric clinical workflows.
RSI Pharmacological Reference Standards
▾
| Agent Class & Generic Name | Standard Clinical Dose | Clinical Onset Time | Duration of Action | Primary Operational Notes |
|---|---|---|---|---|
| Ketamine | 1–2 mg/kg IV | 45–60 sec | 10–20 min | Preferred in shock and bronchospasm; preserves respiratory drive. |
| Propofol | 1.5–2 mg/kg IV | 30–45 sec | 5–10 min | May cause severe hypotension; avoid in hypovolemic or septic shock. |
| Etomidate | 0.3 mg/kg IV | 30–60 sec | 10–15 min | Hemodynamically neutral; associated with transient adrenal suppression. |
| Succinylcholine | 1.5 mg/kg IV | 45–60 sec | 10–15 min | Depolarizing agent; contraindicated in hyperkalemia, burns, and crush injuries. |
| Rocuronium | 1.2 mg/kg IV | 60–90 sec | 45–70 min | Non-depolarizing agent; ideal alternative when succinylcholine is contraindicated. |
| Fentanyl (Pretreatment) | 3 mcg/kg IV | ~3 min | 30–60 min | Blunts sympathetic response to intubation; useful in TBI and aortic dissection. |
| Sugammadex (Reversal) | 16 mg/kg IV | 3 min | Immediate | Used for emergency reversal of Rocuronium in 'cannot intubate, cannot ventilate' scenarios. |
Frequently Asked Questions
▾
What is RSI and what medications are used for rapid sequence intubation?
Rapid Sequence Intubation (RSI) is a specialized clinical procedure designed to rapidly secure a patent airway under emergency conditions while minimizing the risk of gastric aspiration. The protocol involves the sequential administration of a rapid-acting sedative-hypnotic (induction agent) followed immediately by a fast-onset neuromuscular blocker (paralytic). First-line induction agents include Etomidate (0.3 mg/kg IV) for hemodynamic neutrality, Ketamine (1-2 mg/kg IV) for patients in shock or bronchospasm, and Propofol (1.5-2.5 mg/kg IV) for hemodynamically stable patients. The primary paralytics utilized are Succinylcholine and Rocuronium.
What are the adult doses for common RSI paralytic agents?
The two primary neuromuscular blocking agents used in adult RSI are Succinylcholine and Rocuronium. Succinylcholine, a depolarizing blocker, is administered at a standard dose of 1.5 mg/kg IV, offering an onset of 45-60 seconds and a short duration of 6-10 minutes. Rocuronium, a non-depolarizing blocker, is administered at a higher RSI-specific dose of 1.2 mg/kg IV to achieve rapid onset (60-90 seconds) with a longer duration of 45-70 minutes. Rocuronium is highly favored in clinical settings where succinylcholine is contraindicated due to its compatibility with the rapid reversal agent Sugammadex.
What are the adult doses for common RSI sedative-hypnotic agents?
Sedative-hypnotic selection must be tailored to the patient's hemodynamic profile. Etomidate is typically dosed at 0.3 mg/kg IV, providing excellent hemodynamic stability. Ketamine is dosed at 1-2 mg/kg IV, offering dissociative anesthesia and bronchodilation while maintaining blood pressure. Propofol is dosed at 1.5-2 mg/kg IV, providing rapid, reliable sedation but carrying a high risk of systemic vasodilation and hypotension. Midazolam, though less commonly used as a primary RSI agent due to slower onset, is dosed at 0.1-0.3 mg/kg IV.
How should adult RSI medication doses be adjusted for obese patients?
Dosing adjustments in obese patients are critical to avoid toxicities or prolonged drug effects. Lipophilic sedatives like propofol and midazolam should generally be calculated based on Ideal Body Weight (IBW) to prevent oversedation. For paralytics, Succinylcholine should be dosed based on Total Body Weight (TBW) to ensure complete neuromuscular blockade, whereas Rocuronium is best dosed based on IBW to avoid excessively prolonged paralysis.
Are there specific adult dosing considerations for RSI medications in patients with renal or hepatic impairment?
Yes, organ dysfunction significantly alters drug clearance and duration of action. Succinylcholine is contraindicated in patients with severe renal failure and baseline hyperkalemia due to the risk of triggering fatal arrhythmias. Non-depolarizing agents like Rocuronium and Vecuronium rely on hepatic metabolism and renal excretion; their paralytic effects can be significantly prolonged in patients with liver or kidney failure, requiring careful clinical monitoring and potential dose reduction.
Common Mistakes to Avoid
▾
- !Failing to synchronize the administration of the induction agent and the paralytic, which disrupts the rapid sequence workflow and increases the risk of awareness or aspiration.
- !Administering standard doses of propofol to patients with borderline hemodynamics, leading to severe post-induction hypotension and cardiac arrest.
- !Failing to screen for absolute contraindications to succinylcholine, such as pre-existing hyperkalemia, neuromuscular disorders, or major burn injuries older than 24-48 hours.
- !Inadequate pre-oxygenation, which severely limits the safe apnea time and leads to rapid hypoxemia during difficult intubation attempts.
- !Neglecting to prepare a comprehensive backup plan, including a video laryngoscope, supraglottic airway, and emergency surgical airway equipment, prior to administering paralytics.
- !Relying solely on clinical assessment rather than continuous quantitative waveform capnography to confirm correct endotracheal tube placement.
Pro Tip
To optimize clinical safety and team coordination during emergency airway management, implement a standardized 'RSI Checklist' before any drug administration. Ensuring that the entire resuscitation team is aligned on the primary plan, backup plans, and specific drug doses reduces cognitive errors and enhances procedural efficiency under pressure.
Did you know?
The development of Rocuronium in the 1990s, combined with the subsequent introduction of the selective relaxation binding agent Sugammadex, revolutionized clinical airway management. This pharmacological pairing created a high-speed paralytic workflow that can be completely reversed in under three minutes, establishing a major safety benchmark in modern anesthesia and emergency medicine.
References
Read the full guide on how to use this calculator effectively
Skaityti daugiau →Gaukite savaitės matematikos patarimų
Prisijunkite prie 12 000+ prenumeratorių, kurie kiekvieną savaitę gauna skaičiuoklės patarimų.